These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22562114)
1. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. Baldursdottir TR; Bergmann OM; Jonasson JG; Ludviksson BR; Axelsson TA; Björnsson ES Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):824-30. PubMed ID: 22562114 [TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Pla X; Vergara M; Gil M; Dalmau B; Cisteró B; Bella RM; Real J Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):859-64. PubMed ID: 17873609 [TBL] [Abstract][Full Text] [Related]
3. Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. Lazaridis KN; Talwalkar JA J Clin Gastroenterol; 2007; 41(5):494-500. PubMed ID: 17450033 [TBL] [Abstract][Full Text] [Related]
4. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
5. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. ter Borg PC; Schalm SW; Hansen BE; van Buuren HR; Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809 [TBL] [Abstract][Full Text] [Related]
6. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR; Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Myers RP; Shaheen AA; Fong A; Burak KW; Wan A; Swain MG; Hilsden RJ; Sutherland L; Quan H Hepatology; 2009 Dec; 50(6):1884-92. PubMed ID: 19821525 [TBL] [Abstract][Full Text] [Related]
9. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features and prognosis of primary biliary cirrhosis in Korea]. Kim KA; Jeong SH; Lee JI; Yeon JE; Lee HJ; Kwon SY; Chang UI; Min HJ Korean J Hepatol; 2010 Jun; 16(2):139-46. PubMed ID: 20606498 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of primary biliary cirrhosis. Ali AH; Carey EJ; Lindor KD Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237 [TBL] [Abstract][Full Text] [Related]
12. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Rautiainen H; Salomaa V; Niemelå S; Karvonen AL; Nurmi H; Isoniemi H; Färkkilä M Scand J Gastroenterol; 2007 Nov; 42(11):1347-53. PubMed ID: 17918011 [TBL] [Abstract][Full Text] [Related]
14. The natural history of PBC: has it changed? Lee YM; Kaplan MM Semin Liver Dis; 2005 Aug; 25(3):321-6. PubMed ID: 16143947 [TBL] [Abstract][Full Text] [Related]
16. Primary biliary cirrhosis in Southern Israel: a 20 year follow up study. Delgado JS; Vodonos A; Delgado B; Jotkowitz A; Rosenthal A; Fich A; Novack V Eur J Intern Med; 2012 Dec; 23(8):e193-8. PubMed ID: 23022449 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
18. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [TBL] [Abstract][Full Text] [Related]
19. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Floreani A; Caroli D; Variola A; Rizzotto ER; Antoniazzi S; Chiaramonte M; Cazzagon N; Brombin C; Salmaso L; Baldo V Liver Int; 2011 Mar; 31(3):361-8. PubMed ID: 21059170 [TBL] [Abstract][Full Text] [Related]
20. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]